XML 20 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF (LOSS) INCOME - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Revenues $ 2,659.3 $ 2,704.7 $ 2,646.9
Cost of revenues 1,644.7 1,679.1 1,629.7
Gross profit 1,014.6 1,025.6 1,017.2
Selling, general and administrative expenses 873.9 887.5 946.6
Divestiture losses (gains), net 63.4 (15.6) (1.7)
Income from operations 77.3 153.7 72.3
Interest expense, net (73.9) (75.5) (71.9)
Other (expense) income, net (0.1) 0.7 0.3
Income before income taxes 3.3 78.9 0.7
Income tax expense (24.6) (22.4) (27.5)
Net (loss) income (21.3) 56.5 (26.8)
Net income attributable to noncontrolling interests (0.1) (0.5) (1.0)
Net (loss) income attributable to Stericycle, Inc. common shareholders $ (21.4) $ 56.0 $ (27.8)
(Loss) earnings per common share attributable to Stericycle, Inc. common shareholders:      
Basic (in dollars per share) $ (0.23) $ 0.61 $ (0.30)
Diluted (in dollars per share) $ (0.23) $ 0.61 $ (0.30)
Weighted average number of common shares Outstanding:      
Basic (in shares) 92.4 92.1 91.8
Diluted (in shares) 92.4 92.4 91.8